在帕金森病中潜在的生物流体标志物用于认知障碍
Jieyu Chen1, Chunyu Liang, Fang Wang
1Department of Neurology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan Province, China.
Neural regeneration research
|January 24, 2025
概括
在血液和唾液等生物流体中识别帕金森病认知障碍生物标志物至关重要. 这些标志物有助于早期诊断和向治疗,以改善患者的生活质量.
科学领域:
- 神经学 神经学
- 生物化学 生物化学
- 生物标志物发现发现
背景情况:
- 认知障碍是帕金森病 (PD) 的严重非运动症状,严重影响患者的生活质量.
- 早期诊断和针对PD相关认知障碍的向治疗是必不可少的.
- 需要可靠的生物标志物来了解潜在的机制,并监测疾病的进展.
研究的目的:
- 审查最近生物流体生物标志物在帕金森病的认知障碍的进展.
- 探索血液,脑脊液和唾液中的蛋白质,代谢物和其他标记物的潜力.
- 突出生物标志物在了解PD认知衰退病因学方面的作用.
主要方法:
- 关于帕金森病认知障碍生物流体生物标志物的最近研究的文献综述.
- 专注于检测血液,脑脊液和唾液中的蛋白质,代谢物和其他生物标志物.
- 分析生物标志物如何与PD病理生理学有关 (蛋白质错折,神经退行,炎症,氧化应激).
主要成果:
- 生物流体生物标志物在阐明帕金森病中认知障碍的复杂原因方面表现有前途.
- 生物流体标记物与神经成像和临床数据的整合可以改善早期诊断和监测的预测模型.
- 这些生物标志物为PD中神经退行,炎症和氧化应激途径提供了洞察力.
结论:
- 生物流体生物标志物是理解和潜在治疗帕金森病认知障碍的宝贵工具.
- 需要进一步的研究来验证临床效用,并标准化生物标志物用于早期检测和监测.
- 结合生物标志物,神经成像和临床数据的综合方法是推动PD认知健康管理的关键.
更多相关视频
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
7.7K
14:27Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
Published on: June 26, 2013
15.6K
相关概念视频
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Parkinson's Disease: Overview
452
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
452
Parkinson's Disease: Treatment
198
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
198
Alzheimer's Disease: Overview
439
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
439
